Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas

Glioblastoma multiforme (GBM) remains the most devastating primary tumour in neuro-oncology. Targeting of the human epithelial receptor type 2 (HER2)-neu receptor by specific antibodies is a recent well-established therapy for breast tumours. Human epithelial receptor type 2/neu is a transmembrane t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mineo, J-F, Bordron, A, Quintin-Roué, I, Loisel, S, Ster, K L, Buhé, V, Lagarde, N, Berthou, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747695/
https://www.ncbi.nlm.nih.gov/pubmed/15328518
http://dx.doi.org/10.1038/sj.bjc.6602089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747695/
https://www.ncbi.nlm.nih.gov/pubmed/15328518
http://dx.doi.org/10.1038/sj.bjc.6602089

Ejemplares similares